Written by Ad OpsOverview and Naming
Raspberry Bear Claw (CBD) is a CBD-forward cannabis cultivar celebrated for its dessert-leaning bouquet and calm, clear-headed experience. As the name implies, the sensory profile leans into ripe raspberry notes layered over buttery, pastry-like sweetness, landing squarely in the modern 'dessert terp' category. The CBD designation signals a Type III or hemp-compliant chemotype, where CBD is the dominant cannabinoid and delta-9 THC is minimal to trace.
In practice, batches marketed as Raspberry Bear Claw (CBD) typically emphasize flavor-first craft quality while keeping intoxication intentionally low. This makes the cultivar attractive to consumers who want body ease, mood steadiness, and functional focus without a pronounced THC 'high.' In market terms, CBD-dominant flower continues to occupy a meaningful niche; consumer surveys regularly show that 30–45% of respondents are interested in non-intoxicating or low-THC cannabis options for daytime use and symptom relief.
Because publicly available breeder documentation for this specific cultivar is limited, growers and patients often rely on lab certificates of analysis and community reports to characterize it. Across those reports, a consistent through-line emerges: a fragrant, berry-forward nose; dense, frosty flowers; and CBD levels that commonly land in the mid-teens, depending on phenotype and cultivation. That combination of sensory appeal and approachable effects has helped Raspberry Bear Claw (CBD) rise among specialty CBD strains with pastry-inspired names.
History and Breeding Context
Raspberry Bear Claw (CBD) sits within a broader wave of CBD breeding that accelerated between 2013 and 2020. During this period, breeders sought to combine therapeutic cannabinoid ratios with terpene-rich, dispensary-grade flavor reminiscent of top-shelf THC cultivars. The passage of the 2018 U.S. Farm Bill, which federally defined hemp as cannabis with delta-9 THC under 0.3% by dry weight, further catalyzed CBD cultivar development and field-scale production.
As consumer tastes evolved, dessert-themed naming conventions—signaling sweet, bakery-like terpene profiles—gained traction across both THC and CBD markets. Raspberry-forward profiles often trace to selections with ocimene, limonene, and linalool contributions, while 'pastry' undertones suggest the presence of caryophyllene, humulene, and sometimes myrcene-driven creaminess. Raspberry Bear Claw (CBD) follows this sensory trend by pairing fruit aromas with a confectionary back end.
While the exact breeder-origin details for Raspberry Bear Claw (CBD) have not been broadly published, the cultivar’s positioning is clear: craft CBD flower that is terpene-driven, visually striking, and reliable for low-intoxication sessions. In shops that merchandise CBD flower alongside THC varieties, CBD skus often account for 5–15% of total flower offerings, but can represent a higher share of repeat-purchase rates due to daily usability. Within that slice, berry and dessert profiles consistently score well in consumer taste tests for approachability and aroma intensity.
Genetic Lineage and Chemotype
Public, verifiable parentage for Raspberry Bear Claw (CBD) has not been formally disclosed by a widely recognized breeder, and available sources do not provide definitive genetic lineage. Naming conventions and reported traits suggest ancestry influenced by berry-forward lines and possibly broadleaf-dominant stock known for dense bud formation. However, without breeder-released pedigrees and replicated COAs across seed lots, specific parent strains should be treated as unconfirmed.
What is clearer is the chemotype. Raspberry Bear Claw (CBD) is commonly selected and marketed as a Type III cultivar, where CBD is dominant and THC is minimal, often testing at delta-9 THC near or below the hemp threshold of 0.3% by dry weight. Some batches may present as non-hemp Type III cannabis with total THC marginally higher due to measurable THCA, while still maintaining a CBD:THC ratio often in the 15:1 to 30:1 range.
CBD-dominant selections frequently produce total CBD in the 8–18% range in indoor craft conditions, with top-end cuts occasionally surpassing 20% CBD under optimized inputs. Outdoor hemp-compliant production often averages 7–12% CBD while keeping delta-9 THC below 0.3%, depending on harvest timing and environmental stress. Given these market norms, growers should verify the exact chemotype of their Raspberry Bear Claw (CBD) lot via third-party lab testing rather than relying solely on the name.
Appearance and Bud Structure
Grower and buyer reports describe Raspberry Bear Claw (CBD) as producing dense, resinous flowers with a confectionary visual appeal. Buds often take on a conical to spear-shaped form with a medium-high calyx-to-leaf ratio, facilitating hand-trimming without excessive sugar leaf. Under cooler night temperatures, anthocyanin expression can pull in compelling violet hues against a deep forest-green backdrop.
Trichome coverage is a hallmark, with heads that appear plentiful and glassy even under low magnification. Mature colas exhibit a frost that contrasts vividly with bright orange to copper pistils, accentuating the dessert-like aesthetic. In hand, cured buds are typically firm but not rock-hard, compressing slightly and springing back, an indicator of a well-managed dry and cure.
Quality craft batches target a water activity of about 0.55–0.62 at packaging to preserve terpene richness while inhibiting microbial growth. This range supports shelf stability and helps maintain the cultivar’s pastry-forward nose. Properly cured lots will break apart cleanly, shedding intact trichome heads and releasing a concentrated raspberry aroma when ground.
Aroma
The aromatic signature of Raspberry Bear Claw (CBD) leans into layered raspberry, red currant, and sugared berry notes over a warm, bakery-like base. On first crack of the jar, a bright fruit top note arrives quickly, often attributed to ocimene and limonene, which are associated with sweet, fruity, and citrus tones. As the terpene bouquet unfolds, secondary layers may reveal vanilla-adjacent warmth, floral linalool, and a faint hint of spice from beta-caryophyllene.
After grinding, the nose intensifies and rounds out, pulling in soft herbal and musky elements from myrcene and humulene. This phase often adds a faint pastry dough impression, much like the aroma of a warm bakery case. The overall effect is inviting and complex without being cloying, with fruit-forward brightness balanced by bready, mellow undertones.
Across CBD-dominant cultivars with similar profiles, total terpene content commonly ranges from 1.5% to 3.5% by dry weight in craft indoor batches, though exceptional lots can exceed 4%. Within that total, myrcene in the 0.4–1.0% range, limonene at 0.2–0.6%, and ocimene at 0.1–0.4% are typical when berry and confectionary themes dominate. Actual values vary by phenotype, environment, and post-harvest handling; third-party COAs from a given harvest provide the definitive snapshot.
Flavor
On the palate, Raspberry Bear Claw (CBD) tends to mirror the jar aroma with a true-to-nose translation. The inhale often delivers a bright berry entry, while the exhale softens into buttery pastry and light vanilla with a whisper of spice. Limonene and ocimene contribute to the initial pop, while caryophyllene and humulene round out the bakery finish.
Vaporization at lower temperatures, around 175–185°C, emphasizes fruit esters and floral tones, preserving linalool and ocimene contributions. At higher temperatures or with combustion, the flavor skews warmer and spicier, with the berry note giving way to toasted dough and light herbal resin. Many users report the aftertaste as clean, slightly sweet, and lingering, encouraging repeat pulls.
In rosin or flower vapor tests, smoothness is often cited as a strength, provided the flower has been properly flushed and cured. While ash color is not a definitive measure of purity, well-finished batches typically burn evenly and leave minimal harshness in the throat. Because terpenes are volatile, storage at cool temperatures and stable humidity is essential to preserve Raspberry Bear Claw (CBD)'s distinct dessert-berry flavor over time.
Cannabinoid Profile
Raspberry Bear Claw (CBD) is typically selected for a CBD-dominant chemotype with very low delta-9 THC. In hemp-compliant production, delta-9 THC must remain under 0.3% by dry weight; many indoor craft lots target 0.1–0.25% delta-9 THC while still producing 8–16% CBD. Non-hemp Type III batches grown and sold under adult-use or medical cannabis regulations may present slightly higher total THC due to THCA content but frequently maintain a 15:1 or greater CBD:THC ratio.
Beyond CBD and THC, minor cannabinoids can add nuance. CBG often appears in the 0.3–1.5% range in CBD-dominant cultivars, with CBC at 0.1–0.5% and trace THCV occasionally present below 0.2%. Total cannabinoid content for well-grown indoor flower commonly falls between 15% and 22%, with outliers above or below depending on genetics, cultivation, and maturity at harvest.
Decarboxylation dynamics matter when converting flower to edibles or extracts. CBDA converts to CBD efficiently around 110–120°C with sustained heat exposure; a common home decarb protocol is 240°F (115–116°C) for 45–60 minutes to maximize conversion while limiting terpene loss. For inhalation, decarboxylation occurs rapidly at the point of vaporization or combustion, delivering active CBD with a near-immediate onset.
Terpene Profile
While lab-verified terpene breakdowns vary by phenotype and environment, Raspberry Bear Claw (CBD) commonly leans on a fruit-forward ensemble anchored by myrcene, limonene, ocimene, linalool, and caryophyllene. Myrcene, often reported between 0.4% and 1.0% of dry weight in such profiles, contributes to the soft, musky base and can enhance perceived sweetness. Limonene at 0.2–0.6% imparts bright, citrusy lift that keeps the aroma lively.
Ocimene, typically measured at 0.1–0.4%, is associated with sweet, fruity, and herbaceous facets that reinforce the raspberry motif. Linalool in the 0.05–0.25% range can add floral and lightly creamy notes while being studied for potential calming properties. Beta-caryophyllene, often 0.1–0.4%, introduces a subtle peppery warmth and is distinctive for its activity at CB2 receptors, suggesting anti-inflammatory potential in preclinical literature.
Humulene and alpha-pinene frequently appear as supporting actors, together contributing gentle hop-like and pine-fresh edges that keep the profile from collapsing into pure candy. Total terpene content for high-end indoor flower typically lands between 1.5% and 3.5%, a range that correlates with perceived aroma intensity in retail experiences. Because terpenes are sensitive to heat and oxidation, post-harvest handling and storage conditions significantly influence the final sensory expression.
Experiential Effects
Consumers consistently describe Raspberry Bear Claw (CBD) as offering a calm, clear-headed, and physically soothing experience with virtually no intoxication at typical inhaled doses. The onset via inhalation commonly occurs within 1–3 minutes, with effects peaking around 15–30 minutes and tapering over 2–4 hours. Users often report reduction in bodily tension and a gentle mood lift, making it suitable for daytime use or low-stress social settings.
Thanks to very low delta-9 THC, impairment is minimal to negligible for most users. To illustrate the magnitude, a 0.5-gram bowl of 12% CBD and 0.2% delta-9 THC flower contains about 1.0 mg of delta-9 THC. Given inhalation bioavailability estimates that typically range from 10% to 35%, systemic exposure to THC from such a dose would be roughly 0.1–0.35 mg, which most users perceive as sub-threshold.
Dose-response still matters, especially for sedation potential. Lower inhaled doses tend to feel focusing and steady, while larger sessions can encourage relaxation and, in some cases, drowsiness—an effect that may be enhanced if linalool and myrcene levels are higher. Many consumers pair Raspberry Bear Claw (CBD) with work breaks, yoga, or post-exercise recovery, reserving heavier evening doses for winding down without the mental fog of high-THC options.
Potential Medical Uses
CBD has been studied for a range of therapeutic applications, and Raspberry Bear Claw (CBD) offers a user-friendly way to access those effects with a terpene profile that some find particularly soothing. In a 2019 clinical case series examining CBD for anxiety and sleep, 79% of patients reported decreased anxiety scores after one month, and 66% reported improved sleep, with daily oral doses commonly ranging 25–75 mg. While inhaled CBD delivers a different pharmacokinetic profile, many users anecdotally report acute reductions in situational anxiety and physical tension.
For seizure disorders, purified CBD formulations at higher doses have robust evidence. In randomized controlled trials for Lennox-Gastaut and Dravet syndromes, CBD at 10–20 mg/kg/day reduced seizure frequency by a median of roughly 36–42% versus baseline. While flower is not a substitute for prescription-grade CBD in epilepsy management, the data underscore CBD’s neuroactive potential.
In pain and inflammation, the evidence base is mixed but promising in certain contexts. Meta-analyses of cannabinoid therapies show the strongest human evidence for THC:CBD combinations in neuropathic pain, while pure CBD evidence remains more preliminary. Nonetheless, preclinical research indicates CBD may modulate TRPV1, 5-HT1A, adenosine A2A, and inflammatory cytokines, mechanisms consistent with user reports of reduced soreness and improved recovery.
From a practical standpoint, inhaled dosing with Raspberry Bear Claw (CBD) is often titrated in sessions delivering an estimated 20–60 mg CBD, depending on flower potency and device efficiency. For example, vaporizing 0.25 grams of 16% CBD flower contains approximately 40 mg CBD; with inhalation bioavailability variably estimated around 10–35%, absorbed dose might land near 4–14 mg. Individuals seeking sustained effects for anxiety or sleep may layer small inhaled sessions with low-dose oral CBD, always mindful of potential interactions.
Safety considerations are important. CBD can inhibit CYP3A4 and CYP2C19, potentially increasing serum levels of medications like clobazam, warfarin, and certain SSRIs. Common side effects at higher doses include fatigue, dry mouth, and GI upset; very high oral doses have been associated with transient liver enzyme elevations in some patients, underscoring the importance of medical supervision when combining CBD with other medications.
Comprehensive Cultivation Guide
Growth habit and vigor. Raspberry Bear Claw (CBD) typically expresses an indica-leaning structure with sturdy lateral branching and dense internodal stacking in flower. Many CBD-dominant selections prefer moderate feeding and reward attentive environmental control with substantial resin and aroma. Indoors, expect a final stretch of 1.5–2.0x after switching to 12/12, which is manageable with topping and canopy training.
Environment and climate targets. In vegetative growth, maintain 24–28°C daytime temperatures with 60–70% RH and a VPD of 0.9–1.2 kPa to encourage rapid leaf expansion. Early flower thrives at 25–27°C with 50–55% RH and VPD around 1.2–1.4 kPa; late flower benefits from slightly cooler days at 22–26°C and 45–50% RH to control botrytis risk and preserve volatile terpenes. Keep night-to-day differentials around 3–6°C; dipping nights into the 18–20°C range late in flower can safely enhance purple expression on some phenotypes.
Lighting. In veg, target 400–600 µmol/m²/s PPFD for 18 hours per day, translating to a DLI of roughly 26–39 mol/m²/day. In flower, raise PPFD to 800–1,000 µmol/m²/s under 12 hours for a DLI of 34–43 mol/m²/day; resilient CBD cultivars often tolerate 1,100 µmol/m²/s if CO2 is supplemented to 900–1,200 ppm. Balanced spectral
